Beta Bionics Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Sean Saint

Chief executive officer

US$885.7k

Total compensation

CEO salary percentage55.5%
CEO tenure2.5yrs
CEO ownershipn/a
Management average tenure2.3yrs
Board average tenure1.5yrs

Recent management updates

No updates

Recent updates


CEO

Sean Saint (48 yo)

2.5yrs

Tenure

US$885,667

Compensation

Mr. Sean T. Saint, PE serves as CEO & Director at Beta Bionics, Inc. from August, 2022 and serves as its President. He is an engineer, entrepreneur, diabetes technologist and innovator. He served as Presid...


Leadership Team

NamePositionTenureCompensationOwnership
Edward Damiano
Founder & Executive Chairman10.1yrsno datano data
Sean Saint
President2.5yrsUS$885.67kno data
Stephen Feider
CFO, Treasurer & Secretary2.5yrsUS$659.58kno data
Mark Hopman
Chief Commercial Officer1.3yrsUS$992.43kno data
David Henderson
Vice President of Operationsno datano datano data
Kevin Meinert
Vice President of Legal & Business Developmentno datano datano data
Karen Hynes
Vice President of Marketingno datano datano data
Steven Russell
Chief Medical Officer2.3yrsno data0.089%
$ 906.5k
Mike Mensinger
Chief Product Officer1.5yrsno datano data

2.3yrs

Average Tenure

47yo

Average Age

Experienced Management: BBNX's management team is considered experienced (2.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Edward Damiano
Founder & Executive Chairman10.1yrsno datano data
Sean Saint
President2.5yrsUS$885.67kno data
Sean Carney
Independent Director5yrsUS$60.00kno data
Daniel Dearen
Independent Directorless than a yearUS$5.03kno data
Lennox Ketner
Independent Director1.5yrsno datano data
Maria Palasis
Independent Directorless than a yearno datano data
Gilad Glick
Independent Director2.8yrsUS$47.50kno data
Christina Jones
Independent Directorless than a yearno datano data
Adam Lezack
Independent Director1.2yrsUS$47.50kno data

1.5yrs

Average Tenure

54yo

Average Age

Experienced Board: BBNX's board of directors are not considered experienced ( 1.5 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/02 10:24
End of Day Share Price 2025/01/31 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Beta Bionics, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution